Lv6
1920 积分 2021-11-01 加入
Hematuria in Adults
15天前
已完结
Investigating Classroom Environments in Taiwan and Australia With Multiple Research Methods
1个月前
已完结
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
1个月前
已完结
Recommendations for diagnosis and treatment of Atypical Hemolytic Uremic Syndrome (aHUS): an expert consensus statement from the Rare Diseases Committee of the Brazilian Society of Nephrology (COMDORA-SBN)
1个月前
已完结
Complement System Inhibitors in Nephrology: A Comprehensive Review
1个月前
已关闭
Complement dysregulation in glomerulonephritis
1个月前
已完结
New Anticomplement Drugs in Nephrology: Mechanism and Indication
1个月前
已关闭
Complement inhibitors and B cell-modifying agents for IgA nephropathy-a Kidney Disease: Improving Global Outcomes (KDIGO) commentary
1个月前
已关闭
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy
1个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
1个月前
已完结
皖公网安备34019202002308
